Treatment Could Be The Nation’s First Line Of Defense Against Terrorist Smallpox Outbreak
May 15th 2008Drug InformationBio-terrorism
The La Jolla Institute for Allergy & Immunology (LIAI) has received a $7.1 million grant from the National Institutes of Health (NIH) to fund safety and effectiveness testing of an antibody treatment that quickly fights the smallpox virus. The treatment could be the nation’s first line of defense in protecting against a terrorist-originated smallpox outbreak and may eventually be stockpiled nationwide alongside the smallpox vaccine.
More: continued here
No Comments »
Leave a Reply
You must be logged in to post a comment.
